, Tracking Stock Market Picks
Enter Symbol:
Lemaitre Vascular, Inc. (LMAT) [hlAlert]

up 19.90 %

Lemaitre Vascular, Inc. (LMAT) rated Buy with price target $19 by Dougherty & Company

Posted on: Monday,  Dec 7, 2015  2:25 PM ET by Dougherty & Company

Dougherty & Company rated Buy Lemaitre Vascular, Inc. (NASDAQ: LMAT) on 12/07/2015. Previously Dougherty & Company rated Buy Lemaitre Vascular, Inc.
(NASDAQ: LMAT) on 06/19/2015., when the stock price was $11.10. Since then, Lemaitre Vascular, Inc. has gained 19.91% as of 01/20/2016's recent price of $13.31.
If you would have followed the previous Dougherty & Company 's recommendation on LMAT, you would have gained 19.9% of your investment in 215 days.

LeMaitre Vascular, Inc. (LeMaitre Vascular) is a provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices. Its diversified portfolio of peripheral vascular devices consists of products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt-Inahara Carotid Shunt, and VascuTape Radiopaque Tape. The Company offers 14 product lines in three categories, namely Endascular, vascular and general surgery. Its products include thoracic stent grafts, abdominal stent grafts, anastomotic clips, radiopaque tape, valvulotomes, carotid shunts, arterial prostheses, remote endarterectomy devices, covered stents, contrast injectors, balloon catheters, vascular grafts, vein strippers, cholangiogram catheters and vascular access ports.

Team The research group is composed of five senior analysts and two associate analysts. The senior analysts collectively have 44 years of securities industry experience, and include 3 MBA's, 2 CPA's, 2 PE's (professional engineer), a CFA and a CMA. The team has come together out of a passion for overlooked or misunderstood investment opportunities – generally in smaller-cap companies – and a love of in-depth research, with special emphasis on independent information sources and innovative thinking. Coverage Our research coverage is idea driven and balances the twin demands of opportunism for flexibility and universe consistency for maximization of information sources. Current sub-sectors of interest include: * Specialty retail * Internet security * Internet media * Auto-identification and data capture (AIDC & RFID) * Mobile computing * Specialty manufacturing * Chronic care management * Outpatient services * Medical devices * Healthcare IT
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/7/2015 2:25 PM Buy
15.85 19.00
as of 8/27/2015
1 Week up  0.83 %
1 Month up  21.11 %
3 Months up  19.90 %
1 YTD up  19.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/19/2015 1:25 PM Buy
11.10 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy